Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer

Posted: Thursday, March 12, 2020

Enrique Grande, MD, PhD, of MD Anderson Cancer Center, Madrid, discusses the significance of recent findings that showed the efficacy of selpercatinib in RET fusion–positive thyroid cancer and the importance of genetic testing in patients with the malignancy.